These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 32010359)
1. STATINS TREATMENT AND ORO-DENTAL ASPECTS IN A CASE OF HEREDITARY HYPERCHOLESTEROLEMIA IN A CHILD UNDER 6 YEARS. Constantin AT; Covacescu SM; Kozma A; Gherghina I; Lazarescu H Acta Endocrinol (Buchar); 2019; 15(3):378-383. PubMed ID: 32010359 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of Rosuvastatin in Children With Homozygous Familial Hypercholesterolemia and Association With Underlying Genetic Mutations. Stein EA; Dann EJ; Wiegman A; Skovby F; Gaudet D; Sokal E; Charng MJ; Mohamed M; Luirink I; Raichlen JS; Sundén M; Carlsson SC; Raal FJ; Kastelein JJP J Am Coll Cardiol; 2017 Aug; 70(9):1162-1170. PubMed ID: 28838366 [TBL] [Abstract][Full Text] [Related]
4. First case report of familial hypercholesterolemia in an Omani family due to novel mutation in the low-density lipoprotein receptor gene. Al-Hinai AT; Al-Abri A; Al-Dhuhli H; Al-Waili K; Al-Sabti H; Al-Yaarubi S; Al-Hashmi K; Banerjee Y; Al-Zakwani I; Al-Rasadi K Angiology; 2013 May; 64(4):287-92. PubMed ID: 23162007 [TBL] [Abstract][Full Text] [Related]
5. Spectrum of low-density lipoprotein receptor (LDLR) mutations in a cohort of Sri Lankan patients with familial hypercholesterolemia - a preliminary report. Paththinige CS; Rajapakse JRDK; Constantine GR; Sem KP; Singaraja RR; Jayasekara RW; Dissanayake VHW Lipids Health Dis; 2018 May; 17(1):100. PubMed ID: 29720182 [TBL] [Abstract][Full Text] [Related]
6. [Hyperlipoproteinemia and dyslipidemia as rare diseases. Diagnostics and treatment]. Češka R; Štulc T; Votavová L; Schwarzová L; Vaclová M; Freiberger T Vnitr Lek; 2016; 62(11):887-894. PubMed ID: 28128575 [TBL] [Abstract][Full Text] [Related]
7. Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up. Perez de Isla L; Alonso R; Watts GF; Mata N; Saltijeral Cerezo A; Muñiz O; Fuentes F; Diaz-Diaz JL; de Andrés R; Zambón D; Rubio-Marin P; Barba-Romero MA; Saenz P; Sanchez Muñoz-Torrero JF; Martinez-Faedo C; Miramontes-Gonzalez JP; Badimón L; Mata P; J Am Coll Cardiol; 2016 Mar; 67(11):1278-85. PubMed ID: 26988947 [TBL] [Abstract][Full Text] [Related]
8. Guidelines for the management of familial hypercholesterolemia. Harada-Shiba M; Arai H; Oikawa S; Ohta T; Okada T; Okamura T; Nohara A; Bujo H; Yokote K; Wakatsuki A; Ishibashi S; Yamashita S J Atheroscler Thromb; 2012; 19(12):1043-60. PubMed ID: 23095242 [TBL] [Abstract][Full Text] [Related]
9. Imputation of Baseline LDL Cholesterol Concentration in Patients with Familial Hypercholesterolemia on Statins or Ezetimibe. Ruel I; Aljenedil S; Sadri I; de Varennes É; Hegele RA; Couture P; Bergeron J; Wanneh E; Baass A; Dufour R; Gaudet D; Brisson D; Brunham LR; Francis GA; Cermakova L; Brophy JM; Ryomoto A; Mancini GBJ; Genest J Clin Chem; 2018 Feb; 64(2):355-362. PubMed ID: 29038147 [TBL] [Abstract][Full Text] [Related]
10. Treatment pattern of familial hypercholesterolemia in Slovakia: Targets, treatment and obstacles in common practice. Vohnout B; Fábryová Ľ; Klabník A; Kadurová M; Bálinth K; Kozárová M; Bugáňová I; Sirotiaková J; Rašlová K Atherosclerosis; 2018 Oct; 277():323-326. PubMed ID: 30270066 [TBL] [Abstract][Full Text] [Related]
11. Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study. Pirillo A; Garlaschelli K; Arca M; Averna M; Bertolini S; Calandra S; Tarugi P; Catapano AL; Atheroscler Suppl; 2017 Oct; 29():17-24. PubMed ID: 28965616 [TBL] [Abstract][Full Text] [Related]
12. Analysis of Children and Adolescents with Familial Hypercholesterolemia. Minicocci I; Pozzessere S; Prisco C; Montali A; di Costanzo A; Martino E; Martino F; Arca M J Pediatr; 2017 Apr; 183():100-107.e3. PubMed ID: 28161202 [TBL] [Abstract][Full Text] [Related]
13. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene. Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584 [TBL] [Abstract][Full Text] [Related]
14. Characteristics and management of 1093 patients with clinical diagnosis of familial hypercholesterolemia in Greece: Data from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH). Rizos CV; Elisaf MS; Skoumas I; Tziomalos K; Kotsis V; Rallidis L; Garoufi A; Athyros VG; Skalidis E; Kolovou G; Koutagiar I; Papagianni M; Antza C; Katsiki N; Ganotakis E; Liberopoulos EN Atherosclerosis; 2018 Oct; 277():308-313. PubMed ID: 30270064 [TBL] [Abstract][Full Text] [Related]
15. Reducing cardiovascular risk in patients with familial hypercholesterolemia: Risk prediction and lipid management. Miname MH; Santos RD Prog Cardiovasc Dis; 2019; 62(5):414-422. PubMed ID: 31669498 [TBL] [Abstract][Full Text] [Related]
16. A review of gene- and cell-based therapies for familial hypercholesterolemia. Hajighasemi S; Mahdavi Gorabi A; Bianconi V; Pirro M; Banach M; Ahmadi Tafti H; Reiner Ž; Sahebkar A Pharmacol Res; 2019 May; 143():119-132. PubMed ID: 30910740 [TBL] [Abstract][Full Text] [Related]
17. DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores. Miserez AR; Martin FJ; Spirk D Atherosclerosis; 2018 Oct; 277():282-288. PubMed ID: 30270060 [TBL] [Abstract][Full Text] [Related]
18. A Deep Intronic Variant in LDLR in Familial Hypercholesterolemia. Reeskamp LF; Hartgers ML; Peter J; Dallinga-Thie GM; Zuurbier L; Defesche JC; Grefhorst A; Hovingh GK Circ Genom Precis Med; 2018 Dec; 11(12):e002385. PubMed ID: 30562117 [TBL] [Abstract][Full Text] [Related]
19. New Approaches in Detection and Treatment of Familial Hypercholesterolemia. Hartgers ML; Ray KK; Hovingh GK Curr Cardiol Rep; 2015 Dec; 17(12):109. PubMed ID: 26482752 [TBL] [Abstract][Full Text] [Related]